Hargreave Hale AIM VCT plc is a United Kingdom-based venture capital trust that invests in a diversified portfolio of small high-growth companies, primarily listed on AIM, as well as private companies and those on the AQSE Growth Market; its qualifying investments span sectors including technology, healthcare, and consumer discretionary, with non-qualifying holdings in funds such as Marlborough Special Situations and UK Micro-Cap, gold miners ETFs, fixed income securities, UK main market equities, and cash. Founded in 2004 and headquartered at Talisman House, Boardmans Way, Blackpool, England FY4 5FY, the company, managed by Canaccord Genuity Asset Management Limited, targets capital gains and income for shareholders while maintaining VCT status and distributing tax-free dividends. Net assets stand at £130.8 million as of June 2025, with around 55% allocated to approximately 60 VCT-qualifying investments, primarily AIM-quoted. Recent developments include leading a £6.5m investment round in Qureight, a techbio firm specializing in clinical data curation; £3.6 million invested across five qualifying companies in the six months to March 2025, comprising three new and two follow-on investments; post-period investments of £1.8 million in three qualifying deals; appointment of Abbe Martineau as Legal Counsel to the VCT team; and a share buyback of 198,569 ordinary shares at 33.53 pence per share on 26 November 2025.